
RegulatoryNov 20, 2026, 06:45 PM
MEDIROM Regains Nasdaq Periodic Filing Compliance; Bid Price Deficiency Remains
AI Summary
MEDIROM Healthcare Technologies Inc. announced it has regained compliance with Nasdaq's periodic filing requirement after filing its Form 20-F for the year ended December 31, 2025. Nasdaq has closed the matter related to the delayed filing. However, the company still needs to address a separate deficiency regarding the minimum bid price by April 5, 2027. MEDIROM operates wellness salons under the "Re.Ra.Ku®" brand and has expanded into HealthTech with apps and a smart tracker.
Key Highlights
- MEDIROM regained compliance with Nasdaq's periodic filing requirement.
- The company filed its Form 20-F for the year ended December 31, 2025.
- Nasdaq has closed the matter of the delayed annual report filing.
- MEDIROM still faces a minimum bid price deficiency under Nasdaq Listing Rule 5550(a)(2).
- The company has until April 5, 2027, to regain compliance with the bid price requirement.
Price Impact
More from MRM
Delisting3d ago, 5:04 PM
Medirom Receives Nasdaq Delisting Notice, Files Annual Report, Seeks Hearing
Regulatory3d ago, 4:46 PM
Medirom Healthcare Receives Nasdaq Delisting Notice; Appeals Determination
RegulatoryOct 13, 4:31 PM
Medirom Healthcare Technologies Receives Nasdaq Bid Price Non-Compliance Notice